Aim: To study the prevalence of hypertriglyceridemic waist (HTGW) in an urban adult Spanish population and its association with type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Methods: We undertook a cross-sectional analysis in a random sample of 2270 individuals (18-80 years of age). All participants provided a clinical history and underwent a physical examination. Blood and urine analyses were conducted. HTGW was diagnosed using anthropometric criteria for the European population (waist circumference: for men, X94 cm; for women, X80 cm) and fasting plasma triglycerides (TGs) X1.71 mmol l À1 (X150 mg per 100 ml). Results: The prevalence of HTGW was 14.5% (men: 18.2%, women: 10.8%) and was significantly greater in men o59 years (Po0.001). HTGW was associated with older individuals, a low educational level and, in men, with a sedentary lifestyle (Po0.001). Subjects with HTGW had higher levels of total cholesterol, low-density lipoprotein-cholesterol (LDL-c) and uric acid, lower levels of high-density lipoprotein-cholesterol, a higher blood pressure, a greater degree of obesity and a higher prevalence of T2DM (20.00 vs 6.4%, Po0.001) (odds ratio (OR) 3.61; 95% confidence interval (95% CI), 2.60-5.01) and CVD (8.5 vs 3.4%, Po0.001) (OR 2.63; 95% CI, 1.66-4.16). The association of HTGW with T2DM and CVD disappeared after adjusting for age. The degree of concordance between HTGW and the metabolic syndrome (MS) was moderate, with both the Adult Treatment Panel III Report (ATP-III) and the International Diabetes Federation criteria (k ¼ 0.51 and k ¼ 0.58, respectively). Subjects with isolated HTGW as compared with those with isolated MS (ATP-III) were younger, had greater levels of total cholesterol, LDL-c and TGs and a lower prevalence of obesity, high blood pressure and dysglycemia. Conclusion: HTGW is a phenotype of cardiometabolic risk prevalent in the adult population in our environment. HTGW may be an alternative to MS to detect the population at risk for T2DM and CVD, especially in young individuals who do not fulfill the criteria for MS.
Introduction
Intra-abdominal or visceral adiposity is the most common cause of insulin resistance and has been identified as a powerful etiopathogenic factor for the development of type 2 diabetes mellitus (T2DM) and accelerated atherogenesis.
Intra-abdominal fat has metabolic and anatomical characteristics favoring insulin resistance and proinflammatory and procoagulant states, thereby explaining its proatherogenic function. 1 Visceral adipocytes have a high lipolytic activity and increase the release of free-fatty acids in the portal vein, providing the substrate for production of triglyceride (TG)-rich lipoproteins in the liver. 2 Waist circumference (WC) shows a better correlation with intra-abdominal fat than does body mass index (BMI). 3 Moreover, WC is an anthropometric measurement with excellent reproducibility 4 and which is easy to obtain in the primary care setting. 5 Nevertheless, WC does not discriminate between visceral and subcutaneous fat, which explains why an increased waist per se is not sufficient to diagnose intra-abdominal adiposity.
Fasting hypertriglyceridemia could represent a simple clinical marker of excess visceral fat when associated with an increased WC. 1 The proposal of a hypertriglyceridemic waist (HTGW) is based on the concept that abdominal adiposity and dyslipidemia are the pathogenic core of the metabolic syndrome (MS), and are therefore the essential components to identify better those subjects with insulin resistance [6] [7] [8] and a greater atherogenic tendency. [9] [10] HTGW represents an alternative concept to the MS as a simple and reliable phenotype indicator of cardiovascular and metabolic risk associated with visceral obesity, which could improve the ability of primary care physicians to carry out cost-effective screening of the population. Nevertheless, few studies have analyzed the prevalence of the HTGW phenotype in the general adult population. 11 The principal aims of this study were to determine the prevalence of HTGW in an adult urban Spanish population and to analyze its association with T2DM and cardiovascular disease (CVD). The secondary aims were to: (1) 
Materials and methods
We undertook a cross-sectional, analytical, epidemiological study in a representative random sample of the adult population aged 18-80 years, assigned to a health center in Malaga District (n ¼ 29 818 individuals) (Malaga, Spain). The prevalence of MS was used for sample size calculation, assuming a prevalence rate of 20%. Our sample size was calculated to have 480% power with a confidence level of 95% at a ¼ 0.05 and a percentage of losses of 15%. According to this statistical approach, the minimum sample size required was 2167 subjects, stratified by sex and age, extracted by simple random sampling of the complete health card listing provided by the Andalusian Health Service (covering 98% of the population).
Recruitment was carried out between January and June 2007, obtaining a sample of 2492 eligible subjects. Initially, subjects belonging to the randomly selected sample were included consecutively on presentation to the Health Center voluntarily, for whatever reason. After 6 months, the remaining sample patients were located by telephone and invited to participate in the study. Inclusion criteria were individuals aged 18-80 years assigned to the health center who were mobile and who provided written informed consent. Subjects were excluded if they had serious disorders, were terminally ill or immobilized, pregnant, hospitalized at the time of the study or suffered from severe psychiatric disorders, alcoholism or drug addiction. Those individuals who could not be located or refused to participate in the study were considered to be losses.
After obtaining written informed consent, subjects underwent a clinical interview at their usual primary care office. Their education level was classified as low if they were illiterate, had no formal studies or just primary studies. Subjects were considered to lead a sedentary lifestyle if the most they did was just walk, at a moderate pace, no more than 150 min weekly. Measurements of weight, height, BMI, WC (at the level of the mid-point between the anterosuperior iliac crest and the last costal arch, parallel to the ground and exhaling) and blood pressure (mean of three measurements after a 5-min rest) were carried out by previously trained health-care workers (doctors or nurses). Later, blood and urine analyses were carried out after a 12-h fast. Samples were analyzed in the laboratory of the reference hospital and biochemical determinations were obtained by routine methods.
Obesity was considered to be a BMI X30 kg m À2 and overweight as a BMI of 25-29.9 kg m
À2
. Participants were considered to have hypertension if they were taking antihypertensive drugs, had a previous diagnosis of hypertension or their mean systolic blood pressure was X140 mm Hg or mean diastolic blood pressure was X90 mm Hg in the three measurements performed. Participants were considered to be diabetic if they had a previous diagnosis of diabetes, were taking drugs for diabetes or their glycated hemoglobin A1c was X6.5%. A hemoglobin A1c X6% and o6.5% was defined as subdiabetic hyperglycemia.
14 Diagnosis of MS was based on the modified criteria of ATP-III 12 and IDF. 13 CVD was considered to be the presence of a previous history of ischemic cardiomyopathy, heart failure, cerebrovascular disease, aortic aneurysm or peripheral arterial disease. For the diagnosis of HTGW, we used WC thresholds currently recommended by WHO (World Health Organization) in Europids (WC X94 cm for men and X80 cm for women) 15 and fasting plasma TGs X1.71 mmol l À1 (X150 mg per 100 ml).
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Statistical analysis
The prevalence of HTGW and the degree of concordance between HTGW and MS was determined by the k-index. Prevalence rates of MS were 27.2% (95% confidence interval (95% CI), 25.3-29.0) (IDF criteria) and 23.1% (95% CI, 21.3-24.8) (ATP-III criteria). The mean age of subjects with MS was 53.5±14.6 years (ATP-III) and 53.9±14.7 years (IDF). Table 1 shows the clinical and biochemical differences between subjects with and without HTGW; 330 subjects met the HTGW criteria (14.5%). The prevalence of HTGW was significantly greater in men (18.2%) than in women (10.8%) (Po0.001). Subjects with HTGW had a higher mean age, significantly more obesity (with greater BMI and greater WC), as well as higher systolic and diastolic blood pressure levels. HTGW was also significantly associated with a lower educational level and a greater sedentary lifestyle, but not with smoking. Subjects with HTGW had higher levels of glycemia, hemoglobin A1c, total cholesterol, low-density lipoprotein-cholesterol (LDL-c), TGs, non-high-density lipoprotein-cholesterol (HDL-c), total cholesterol:HDL-c ratio, creatinine and uric acid, as well as lower HDL-c levels. The prevalence of T2DM (20.0 vs 6.4%) and that of CVD (8.5 vs 3.4%) was significantly increased in the HTGW population (Po0.001).
The presence of HTGW was associated with T2DM, CVD and coronary heart disease, with an odds ratio (OR) (95% CI) of 3. HTGW and MS R Gomez-Huelgas et al 34.4%) (Po0.001). A greater proportion of diabetics with HTGW were men (63.9 vs 36.1%) (Po0.001), but there were no differences in the mean age or in the proportion of individuals older than 50 years of age among diabetics with and without HTGW.
The prevalence of HTGW increased with age, reaching 25% in those aged 50-59 years. A marked reduction was found in the prevalence of HTGW with effect from 70 years of age. HTGW was significantly more prevalent in men aged 20-59 years, with the prevalence becoming similar in the two sexes after this age (Figure 1 ).
Analysis by sex of different characteristics in the population with HTGW (Table 2) showed that women were older and had a lower educational level, a greater prevalence of obesity and hypertension, as well as higher subdiabetic hyperglycemia and microalbuminuria levels, whereas men had a greater prevalence of overweight and smoking, a lower HDL-c, as well as higher TG, creatinine and uric acid levels. No differences were found by sex in the other study variables, including the prevalence of T2DM or CVD.
Multivariate analysis identified age, male sex, a low cultural level and a sedentary lifestyle, but not smoking, as risk factors for HTGW. A sedentary lifestyle was associated with HTGW in men but not in women ( Table 3) .
The association between CVD and HTGW remained after adjusting for sex, mean blood pressure, smoking, a sedentary lifestyle, glycemia, LDL-c and HDL-c, but disappeared after adjusting for age. The association between T2DM and HTGW also remained after adjusting for other factors (such as sex, smoking, a sedentary lifestyle), but disappeared after adjusting for age and BMI. HTGW and MS R Gomez-Huelgas et al discordant populations (subjects with criteria of HTGW but without MS, or with MS criteria but without HTGW) is shown in Table 4 . The phenotype of isolated HTGW, in comparison with that of isolated MS (criteria ATP-III), was more frequent in younger subjects, men and in those with higher total cholesterol, LDL-c, non-HDL-c and TG levels. The phenotype of MS (ATP-III) without HTGW predominated in older women, with greater obesity and a higher prevalence of hypertension, dysglycemia, T2DM and CVD.
Discussion
In our study population, with a high rate of overweight and/or obesity (61.3%), the prevalence of a HTGW phenotype (14.5%) was lower than the prevalence of MS, by both the ATP-III (23.1%) and the IDF criteria (27.2%). To date, no diagnostic criteria have been defined for HTGW, which prevents comparative epidemiological analyses. Consequently, the reported prevalence of HTGW largely depends on the criteria used and the population studied.
11, [16] [17] [18] [19] [20] [21] [22] [23] [24] As found in other studies, 11, 19 the prevalence of HTGW was greater in men and increased with age. The lower prevalence of HTGW we found in the elderly population is probably a survival bias, considering the atherogenic profile associated with HTGW. As expected, the great majority (490%) of our population with HTGW presented overweight or obesity. Coinciding with other studies, 11, 21 the HTGW phenotype was more prevalent in the sedentary population and in those with a low academic level. However, in the multivariate analysis, a sedentary lifestyle was only associated with HTGW in men, but not in women. Recently, a sex-smoking interaction has been reported in the accumulation of visceral fat, such that HTGW and MS R Gomez-Huelgas et al smoking reduces visceral adiposity in women but not in men, 25 although our results fail to support an association between HTGW and smoking, independently of the sex. We found that those individuals with the HTGW phenotype had higher levels of blood pressure, glycemia, total cholesterol, LDL-c and uric acid, and a lower HDL-c concentration, independently of sex and age. This association of the HTGW phenotype with classic risk factors has been noted by other authors. 11, 16, 17, 19, 21 In addition, the HTGW is closely related with other highly atherogenic lipid alterations, such as the metabolic triad (hyperinsulinemia, hyperapolipoproteinemia B and small and dense LDL particles) 23, 26 and postprandial hyperlipidemia. 27 Finally, HTGW can also be a good indicator of the presence of alterations in carbohydrate metabolism. 24 Our population with HTGW presented a greater prevalence of subdiabetic hyperglycemia and/or T2DM than did subjects without HTGW (32.7 vs 18.2%) (Po0.001). In particular, the OR (95% CI) for the presence of T2DM with respect to subjects without HTGW was 3.61 (2.60-5.01), almost identical to that reported by Kahn and Valdez, 11 although in this study, the risk for diabetes was lower in men than in women with HTGW. In our analysis, the association between HTGW and T2DM disappeared after adjustment for age or BMI. We found that HTGW retained a significant association with the presence of CVD, after adjustment for cardiovascular risk factors and physical activity, but this association disappeared after adjusting for age. Evidence exists for the association of HTGW with CVD in both cross-sectional 22, 28 and prospective studies. 18, 20, 21, 24 The vascular risk associated with HTGW has been documented in both normoglycemic individuals and in those with impaired glucose intolerance and T2DM. 18, 20, 24 In fact, the coronary risk associated with the presence of impaired fasting glucose may be completely attributable to the coexistence of HTGW.
28
A recent report showed that HTGW in subjects with T2DM identifies a subgroup with greater visceral adiposity and a greater degree of subclinical coronary atherosclerosis.
29 Surprisingly, in our study, we did not find that diabetic patients with HTGW had a higher risk of CVD, although the small sample size impedes drawing firm conclusions. Although we found no differences in age between diabetics with and without HTGW, the greater proportion of male diabetics without HTGW could explain, at least in part, this greater rate of CVD. On the other hand, we are unaware of the evolution time of diabetes, a key factor for analyzing the prevalence of CVD in a diabetic population. We found a moderate degree of concordance between HTGW and MS, another clinical surrogate marker of abdominal adiposity and associated risk factors. Some studies have suggested that HTGW may be a better phenotype marker than MS of the presence of the atherogenic metabolic triad. 30 Other studies, including that by Tankó et al. 20 in postmenopausal women and St-Pierre et al. 24 in subjects with T2DM or impaired glucose intolerance, failed to find that MS (ATP-III criteria) improves the predictive capacity of HTGW for CVD, which is why HTGW could be a simpler concept for population screening. Nevertheless, in our observational study, MS, defined with either the ATP-III or the IDF criteria, was associated with a greater OR of CVD and coronary heart disease than HTGW and also of T2DM. On the basis of our results, HTGW seems to be a worse predictor of the cardiometabolic risk, and potential mortality, than MS. This may be because HTGW, which just brings together two components of MS, underestimates the risk, although we cannot rule out the possibility that they are two separate entities. In addition, the population with HTGW was younger than that with MS, which could partly explain the lower association with CVD and T2DM.
A very important observation in our study is the finding that subjects who were discordant for HTGW vs MS (ATP-III) were also metabolically different. In our study, subjects with isolated HTGW as compared with those with isolated MS (ATP-III) were younger and had higher levels of total cholesterol, LDL-c and TGs, whereas individuals with isolated MS (ATP-III) without HTGW were almost 13 years older and presented greater overall and abdominal obesity and a higher prevalence of elevated blood pressure and dysglycemia. These data coincide with those of Kahn and Valdez 11 in a NorthAmerican population, although we did not find lower HDL-c levels in subjects with isolated MS. It has been indicated that patients with MS (ATP-III) may constitute a population with a greater degree of insulin resistance than subjects with isolated HTGW. 11 In our opinion, HTGW may be an earlier marker than MS of visceral adiposity, and it may therefore be particularly useful clinically in young individuals who do not fulfill the criteria for MS. Our study has certain limitations. The study population was exclusively Caucasian, urban and with a lower-middle socioeconomic level; therefore, the results cannot be extrapolated to other types of population. Nevertheless, the large sample size, the low number of losses and the fact that it involved the general population all contribute strength to the results. We did not use a validated questionnaire, and the estimated physical activity levels may therefore be inadequate. As this study was observational, we cannot establish any causal relations, which would require prospective studies analyzing the predictive usefulness of HTGW as a cardiometabolic risk indicator.
Our data obtained from a sample of the general adult population indicate that the prevalence of HTGW is high, increases with age, is greater in men and is closely associated with a low educational level, a sedentary lifestyle and obesity. Our findings agree with previous studies in which the presence of HTGW was associated with a greater risk of T2DM and CVD, independently of sex and other risk factors, although this association disappeared after adjusting for age. The concordance between HTGW and MS was moderate.
Although in comparison with other countries, the prevalence of CVD is lower in Spain, 31 CVD continues to be the main cause of death in our country 32 and presents an increasing tendency determined by the 'diabesity'
HTGW and MS R Gomez-Huelgas et al epidemic, 33 which reinforces the need to find efficient and practical risk markers, applicable at both individual and population levels. Although compared with MS, HTGW showed a lower predictive capacity of CVD and T2DM, HTGW may be a simple and applicable clinical tool to detect subjects with cardiometabolic risk, particularly in young individuals who do not fulfill the criteria for MS. However, prospective studies are necessary to evaluate the usefulness of this simple cardiometabolic risk indicator.
